Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Teriparatide [rhPTH (1-34)], but not strontium ranelate, demonstrated bone anabolic efficacy in mature, osteopenic, ovariectomized rats.

Ma YL, Zeng QQ, Porras LL, Harvey A, Moore TL, Shelbourn TL, Dalsky GP, Wronski TJ, Aguirre JI, Bryant HU, Sato M.

Endocrinology. 2011 May;152(5):1767-78. doi: 10.1210/en.2010-1112. Epub 2011 Feb 22.

PMID:
21343258
2.

Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH.

Bone. 2010 Apr;46(4):935-9. doi: 10.1016/j.bone.2009.12.032. Epub 2010 Jan 6.

PMID:
20060081
3.

Patient experience with a new teriparatide delivery device.

Dore RK, Feldman RG, Taylor KA, See K, Dalsky GP, Warner MR.

Curr Med Res Opin. 2009 Oct;25(10):2413-22. doi: 10.1185/03007990903173074.

PMID:
19656016
4.

Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures.

Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, García-Hernández PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC.

J Bone Miner Res. 2010 Feb;25(2):404-14. doi: 10.1359/jbmr.090731.

5.

Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study.

Minne H, Audran M, Simões ME, Obermayer-Pietsch B, Sigurðsson G, Marín F, Dalsky GP, Nickelsen T; EUROFORS Study Group.

Curr Med Res Opin. 2008 Nov;24(11):3117-28. doi: 10.1185/03007990802466595. Epub 2008 Oct 6.

PMID:
18838053
6.

Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R.

N Engl J Med. 2007 Nov 15;357(20):2028-39.

7.

Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis.

Adami S, San Martin J, Muñoz-Torres M, Econs MJ, Xie L, Dalsky GP, McClung M, Felsenberg D, Brown JP, Brandi ML, Sipos A.

Osteoporos Int. 2008 Jan;19(1):87-94. Epub 2007 Oct 16.

PMID:
17938984
8.

Severity of vertebral fracture reflects deterioration of bone microarchitecture.

Genant HK, Delmas PD, Chen P, Jiang Y, Eriksen EF, Dalsky GP, Marcus R, San Martin J.

Osteoporos Int. 2007 Jan;18(1):69-76. Epub 2006 Oct 7.

PMID:
17028792
9.

Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis.

Ma YL, Zeng Q, Donley DW, Ste-Marie LG, Gallagher JC, Dalsky GP, Marcus R, Eriksen EF.

J Bone Miner Res. 2006 Jun;21(6):855-64.

10.

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass.

McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, Donley DW, Dalsky GP, Eriksen EF.

Arch Intern Med. 2005 Aug 8-22;165(15):1762-8. Erratum in: Arch Intern Med. 2005 Oct 10;165(18):2120.

PMID:
16087825
11.

Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment.

Prince R, Sipos A, Hossain A, Syversen U, Ish-Shalom S, Marcinowska E, Halse J, Lindsay R, Dalsky GP, Mitlak BH.

J Bone Miner Res. 2005 Sep;20(9):1507-13. Epub 2005 May 2.

12.

Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.

Arlot M, Meunier PJ, Boivin G, Haddock L, Tamayo J, Correa-Rotter R, Jasqui S, Donley DW, Dalsky GP, Martin JS, Eriksen EF.

J Bone Miner Res. 2005 Jul;20(7):1244-53. Epub 2005 Mar 14.

13.

Dual-energy X-ray absorptiometry of birds: an examination of excised skeletal specimens.

Dirrigl FJ, Dalsky GP, Warner SE.

J Vet Med A Physiol Pathol Clin Med. 2004 Aug;51(6):313-9.

PMID:
15485568
14.

Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy.

Kaufman JM, Orwoll E, Goemaere S, San Martin J, Hossain A, Dalsky GP, Lindsay R, Mitlak BH.

Osteoporos Int. 2005 May;16(5):510-6. Epub 2004 Aug 18.

PMID:
15322742
15.

Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis.

Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL.

J Bone Miner Res. 2003 Mar;18(3):539-43.

16.

Bone mineral density of competitive male mountain and road cyclists.

Warner SE, Shaw JM, Dalsky GP.

Bone. 2002 Jan;30(1):281-6.

PMID:
11792598
17.

Comparison of accelerometers with oxygen consumption in older adults during exercise.

Fehling PC, Smith DL, Warner SE, Dalsky GP.

Med Sci Sports Exerc. 1999 Jan;31(1):171-5.

PMID:
9927026
18.

Calciotropic hormones and bone markers in the elderly.

Gallagher JC, Kinyamu HK, Fowler SE, Dawson-Hughes B, Dalsky GP, Sherman SS.

J Bone Miner Res. 1998 Mar;13(3):475-82.

19.

Economy of mobility in older adults.

Davies MJ, Dalsky GP.

J Orthop Sports Phys Ther. 1997 Aug;26(2):69-72.

PMID:
9243404
20.

Body composition and health-related quality of life in patients with obstructive airways disease.

Shoup R, Dalsky G, Warner S, Davies M, Connors M, Khan M, Khan F, ZuWallack R.

Eur Respir J. 1997 Jul;10(7):1576-80.

21.

Normalizing strength for body size differences in older adults.

Davies MJ, Dalsky GP.

Med Sci Sports Exerc. 1997 May;29(5):713-7.

PMID:
9140912
22.

Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women.

Krall EA, Dawson-Hughes B, Hirst K, Gallagher JC, Sherman SS, Dalsky G.

J Gerontol A Biol Sci Med Sci. 1997 Mar;52(2):M61-7.

PMID:
9060971
23.

Alterations in total and regional body composition in patients with moderate to severe obstructive lung disease.

ZuWallack RL, Shoup R, Warner S, Davies M, Khan F, Dalsky G.

Monaldi Arch Chest Dis. 1996 Dec;51(6):507-9. No abstract available.

PMID:
9046164
24.

Sodium excretion influences calcium homeostasis in elderly men and women.

Dawson-Hughes B, Fowler SE, Dalsky G, Gallagher C.

J Nutr. 1996 Sep;126(9):2107-12.

PMID:
8814198
25.

Guidelines for diagnosing osteoporosis.

Dalsky GP.

Phys Sportsmed. 1996 Jul;24(7):96-100. doi: 10.3810/psm.1996.07.1419.

PMID:
20087009
26.

Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty.

Rubin K, Schirduan V, Gendreau P, Sarfarazi M, Mendola R, Dalsky G.

J Pediatr. 1993 Dec;123(6):863-70.

PMID:
8229518
27.

Effect of endurance training on plasma free fatty acid turnover and oxidation during exercise.

Martin WH 3rd, Dalsky GP, Hurley BF, Matthews DE, Bier DM, Hagberg JM, Rogers MA, King DS, Holloszy JO.

Am J Physiol. 1993 Nov;265(5 Pt 1):E708-14.

PMID:
8238496
28.

Bone mineral density in elite junior Olympic weightlifters.

Conroy BP, Kraemer WJ, Maresh CM, Fleck SJ, Stone MH, Fry AC, Miller PD, Dalsky GP.

Med Sci Sports Exerc. 1993 Oct;25(10):1103-9.

PMID:
8231753
29.

Body composition of healthy sedentary and trained, young and older men and women.

Kohrt WM, Malley MT, Dalsky GP, Holloszy JO.

Med Sci Sports Exerc. 1992 Jul;24(7):832-7.

PMID:
1501570
30.

Osteoporosis and exercise in women.

Marcus R, Drinkwater B, Dalsky G, Dufek J, Raab D, Slemenda C, Snow-Harter C.

Med Sci Sports Exerc. 1992 Jun;24(6 Suppl):S301-7. Review. No abstract available.

PMID:
1625555
31.

Insulin secretory capacity in endurance-trained and untrained young men.

King DS, Staten MA, Kohrt WM, Dalsky GP, Elahi D, Holloszy JO.

Am J Physiol. 1990 Aug;259(2 Pt 1):E155-61.

PMID:
2200274
32.

Effect of exercise on bone: permissive influence of estrogen and calcium.

Dalsky GP.

Med Sci Sports Exerc. 1990 Jun;22(3):281-5. Review.

PMID:
2199749
33.

The role of exercise in the prevention of osteoporosis.

Dalsky GP.

Compr Ther. 1989 Sep;15(9):30-7. Review.

PMID:
2676332
34.

The role of exercise in preventing osteoporosis.

Birge SJ, Dalsky G.

Public Health Rep. 1989 Sep-Oct;104 Suppl:54-8. Review.

35.

Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.

Tuttle KR, Marker JC, Dalsky GP, Schwartz NS, Shah SD, Clutter WE, Holloszy JO, Cryer PE.

Am J Physiol. 1988 Jun;254(6 Pt 1):E713-9.

PMID:
3287952
36.

Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women.

Dalsky GP, Stocke KS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ Jr.

Ann Intern Med. 1988 Jun;108(6):824-8.

PMID:
3259410
37.

Effects of exercise and lack of exercise on insulin sensitivity and responsiveness.

King DS, Dalsky GP, Clutter WE, Young DA, Staten MA, Cryer PE, Holloszy JO.

J Appl Physiol (1985). 1988 May;64(5):1942-6.

PMID:
3292505
38.

Effects of lack of exercise on insulin secretion and action in trained subjects.

King DS, Dalsky GP, Clutter WE, Young DA, Staten MA, Cryer PE, Holloszy JO.

Am J Physiol. 1988 May;254(5 Pt 1):E537-42.

PMID:
3284381
39.

Insulin action and secretion in endurance-trained and untrained humans.

King DS, Dalsky GP, Staten MA, Clutter WE, Van Houten DR, Holloszy JO.

J Appl Physiol (1985). 1987 Dec;63(6):2247-52.

PMID:
3325486
40.

Exercise: its effect on bone mineral content.

Dalsky GP.

Clin Obstet Gynecol. 1987 Dec;30(4):820-32. Review. No abstract available.

PMID:
3319315
41.

Epinephrine is not critical to prevention of hypoglycemia during exercise in humans.

Hoelzer DR, Dalsky GP, Schwartz NS, Clutter WE, Shah SD, Holloszy JO, Cryer PE.

Am J Physiol. 1986 Jul;251(1 Pt 1):E104-10. Retraction in: Cryer PE. Am J Physiol. 1989 Feb;256(2 Pt 1):E338. J Clin Invest. 1989 Mar;83(3):1085.

PMID:
3524257
42.

Muscle triglyceride utilization during exercise: effect of training.

Hurley BF, Nemeth PM, Martin WH 3rd, Hagberg JM, Dalsky GP, Holloszy JO.

J Appl Physiol (1985). 1986 Feb;60(2):562-7.

PMID:
3512511
43.
44.

Effects of high-intensity strength training on cardiovascular function.

Hurley BF, Seals DR, Ehsani AA, Cartier LJ, Dalsky GP, Hagberg JM, Holloszy JO.

Med Sci Sports Exerc. 1984 Oct;16(5):483-8.

PMID:
6513767
45.

Elevated high-density lipoprotein cholesterol levels in older endurance athletes.

Seals DR, Allen WK, Hurley BF, Dalsky GP, Ehsani AA, Hagberg JM.

Am J Cardiol. 1984 Aug 1;54(3):390-3.

PMID:
6465022
46.

Glucose tolerance in young and older athletes and sedentary men.

Seals DR, Hagberg JM, Allen WK, Hurley BF, Dalsky GP, Ehsani AA, Holloszy JO.

J Appl Physiol Respir Environ Exerc Physiol. 1984 Jun;56(6):1521-5.

PMID:
6376436
47.

Physiological Effects of Power Volleyball.

Conlee RK, McGown CM, Fisher AG, Dalsky GP, Robinson KC.

Phys Sportsmed. 1982 Feb;10(2):93-97. doi: 10.1080/00913847.1982.11947167.

PMID:
29261086
48.

The influence of free fatty acids on glycogen recovery in rat heart after exercise.

Conlee RK, Dalsky GP, Robinson KC.

Eur J Appl Physiol Occup Physiol. 1981;47(4):377-83.

PMID:
7199440
49.

Effects of caffeine ingestion on metabolism and exercise performance.

Costill DL, Dalsky GP, Fink WJ.

Med Sci Sports. 1978 Fall;10(3):155-8.

PMID:
723503
50.

Effects of elevated plasma FFA and insulin on muscle glycogen usage during exercise.

Costill DL, Coyle E, Dalsky G, Evans W, Fink W, Hoopes D.

J Appl Physiol Respir Environ Exerc Physiol. 1977 Oct;43(4):695-9.

PMID:
908685

Supplemental Content

Loading ...
Support Center